A new method to measure the impact of sleep apnea on health
A novel tool to quantify hypoxia burden from clinical sleep studies
This study is looking to better understand how obstructive sleep apnea affects heart health and brain function by creating a new way to measure its severity, which could help improve care for people with this condition.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-11004993 on NIH RePORTER |
What this research studies
This research focuses on improving the understanding of obstructive sleep apnea (OSA) and its health impacts, particularly on cardiovascular health and cognitive function. It aims to develop a novel mathematical model that quantifies the severity of OSA by analyzing existing sleep study data more accurately than current methods. By addressing the limitations of traditional indicators like the apnea-hypopnea index and pulse oximetry, this project seeks to provide a clearer picture of how OSA affects patients at the tissue level. This could lead to better assessments and management of OSA-related health issues.
Who could benefit from this research
Good fit: Ideal candidates for this research are middle-aged individuals diagnosed with obstructive sleep apnea.
Not a fit: Patients without a diagnosis of obstructive sleep apnea or those with mild symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment strategies for patients suffering from obstructive sleep apnea.
How similar studies have performed: Previous research has shown that innovative modeling approaches can enhance the understanding of sleep apnea and its effects, suggesting potential for success in this novel approach.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Grosberg, Anna — University of California-Irvine
- Study coordinator: Grosberg, Anna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.